News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
37–72
Matches
2590
Sources here
12
Companies here
29
Search results Stored financial headlines

Active search

2590 matching headlines

Ticker or company: NOVMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

RenovoRx (NASDAQ:RNXT) Upgraded to "Hold" at Wall Street Zen

Wall Street Zen has upgraded RenovoRx (NASDAQ:RNXT) from a "sell" to a "hold" rating, while the overall analyst consensus remains a "Moderate Buy" with an $8.50 average price target. The company reported a narrower-than-expected quarterly loss of $0.05 per share and revenues of $0.91 …

RNXT main company
Sharemaestro market context Trend signal started 52 weeks +48.9% · Next-week setup negative 29.7% RNXT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CoreCap Advisors LLC Sells 29,027 Shares of The Hanover Insurance Group, Inc. $THG

CoreCap Advisors LLC significantly reduced its stake in The Hanover Insurance Group (THG) by selling 29,027 shares, retaining only 178 shares. Despite this, institutional investors still hold 86.61% of the company, which recently reported strong quarterly earnings, authorized a $700 million share-repurchase program, and …

THG main company
Sharemaestro market context Trend signal active 52 weeks +30.9% THG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

D.A. Davidson & CO. Lowers Position in Novartis AG $NVS

D.A. Davidson & CO. reduced its stake in Novartis AG (NYSE:NVS) by 23.4% in the second quarter, selling 49,798 shares and holding 163,017 shares valued at $25.55 million. Despite this, several other institutional investors, including Auto Owners Insurance Co. and Morgan Stanley, significantly increased …

NVS main company
Sharemaestro market context Trend signal active 52 weeks +22.5% · Next-week setup positive 61.2% NVS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Dimensional Fund Advisors LP Sells 103,356 Shares of Immunovant, Inc. $IMVT

Dimensional Fund Advisors LP significantly reduced its stake in Immunovant, Inc. (NASDAQ:IMVT) by selling 103,356 shares, retaining 57,086 shares valued at $1.42 million. This comes as Immunovant's insiders, including the CTO and COO, also sold a substantial number of shares recently. Analysts currently rate …

IMVT main company
Sharemaestro market context Trend signal active 52 weeks +174.4% · Next-week setup negative 44.7% IMVT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

INNOVATE (NYSE:VATE) Upgraded by Wall Street Zen to Strong-Buy Rating

Wall Street Zen has upgraded INNOVATE (NYSE:VATE) from a "buy" to a "strong-buy" rating, despite Weiss Ratings maintaining a "sell (e+)" and the overall MarketBeat consensus being "Sell." INNOVATE recently reported strong quarterly earnings, beating estimates significantly with $0.71 EPS and $421.6 million in …

VATE main company
Sharemaestro market context Price below Trend Line 52 weeks +63.1% VATE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Fortune Brands (FBIN) Has Investors Watching, What Is Behind The Latest Attention?

Fortune Brands Innovations (FBIN) is garnering renewed investor attention due to recent earnings, updated 2026 guidance, ongoing share repurchases, and engagement from Pictet Asset Management. Despite a recent share price easing, the company is seen as potentially undervalued, trading below analyst targets and an …

FBIN main company
Sharemaestro market context Price above Trend Line 52 weeks -20.9% · Next-week setup negative 43.0% FBIN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Inovio Pharmaceuticals (NASDAQ:INO) Upgraded to "Hold" at Wall Street Zen

Wall Street Zen has upgraded Inovio Pharmaceuticals (NASDAQ:INO) from a "Sell" to a "Hold" rating, though overall analyst opinions remain mixed, with MarketBeat reporting a "Moderate Buy" consensus. The company recently exceeded earnings estimates, reporting a quarterly EPS of negative $0.07 against an expected …

INO main company
Sharemaestro market context Price below Trend Line 52 weeks -44.4% · Next-week setup negative 43.9% INO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

NOVONIX Stock Scheduled to Reverse Split on Thursday, August 27th (NASDAQ:NVX)

NOVONIX Limited (NASDAQ:NVX) is scheduled to execute a 1-for-10 reverse stock split on Thursday, August 27th, with shareholder adjustments taking place after market close on August 26th. The stock recently traded near its 52-week low at $0.44 and has a consensus "Sell" rating from …

NVX main company
Sharemaestro market context Price below Trend Line 52 weeks -69.3% · Next-week setup negative 40.5% NVX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Annovis Bio (ANVS) posts $32.4M loss and warns on going-concern risk

Annovis Bio reported a six-month net loss of $32.4 million, primarily due to increased research and development expenses for its Alzheimer's and Parkinson's disease clinical trials. The company's cash and cash equivalents stood at $18.7 million, with management warning that these funds are only …

ANVS main company
Sharemaestro market context Price below Trend Line 52 weeks -21.9% ANVS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Paul Voigt Discloses Investment at INNOVATE Corp. with 7.4% Stake

Paul Voigt, Interim CEO of INNOVATE Corp. (VATE), has disclosed a 7.4% beneficial stake in the company, detailed in a Schedule 13D filing from August 14, 2026. This stake includes options, shares from compensation, and personal purchases, signaling his commitment as an operator-investor. Voigt …

VATE main company
Sharemaestro market context Price below Trend Line 52 weeks +63.1% VATE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Onto Innovation (ONTO) Is Up 7.6% After Raising Q3 Revenue And Earnings Guidance – What's Changed

Onto Innovation (ONTO) saw its stock rise by 7.6% after increasing its Q3 revenue and earnings guidance. The company reported strong Q2 results and projects Q3 revenue between US$380 million and US$400 million, with diluted EPS of US$1.54 to US$1.70, reinforcing its investment narrative …

ONTO main company
Sharemaestro market context Trend signal active 52 weeks +205.7% ONTO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

(HNVR) as a Liquidity Pulse for Institutional Tactics

This article provides an AI-driven analysis of Hanover Bancorp Inc. (HNVR), identifying strong near and mid-term sentiment, potential for compelling upside, and no clear price positioning signal. It outlines three institutional trading strategies (Position, Momentum Breakout, Risk Hedging) with specific entry, target, and stop-loss …

HNVR main company
Sharemaestro market context Trend signal active 52 weeks +25.4% · Next-week setup negative 44.9% HNVR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Is Scholar Rock Holding Corporation (SRRK) Better Positioned than Novo Nordisk A/S (NVO) After Recent Setbacks?

Two healthcare players, Scholar Rock Holding Corporation (NASDAQ:SRRK) and Novo Nordisk A/S (NYSE:NVO), find their near-term narratives intertwined over manufacturing compliance. One is smoothly navigating a supply chain hurdle ahead of a critical drug approval, while the other just delivered a complicated financial quarter. …

NOVOBN main company NVON main company NOVO-B main company N1VO34 main company NVO main company NNO2 main company +1 more
Sharemaestro market context Trend signal started 52 weeks -24.4% · Next-week setup negative 40.6% NOVOBN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

How (ISSC) Movements Inform Risk Allocation Models

This article analyzes Innovative Solutions And Support Inc. (NASDAQ: ISSC) using AI models to inform risk allocation. It highlights a strong sentiment across all time horizons supporting an overweight bias, with exceptional risk-reward setups. The report provides specific trading strategies—Position Trading, Momentum Breakout, and …

ISSC main company
Sharemaestro market context Price above Trend Line 52 weeks +61.6% · Next-week setup positive 55.7% ISSC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Jim Cramer Reevaluates Novo Nordisk (NVO) as Wegovy Pill Adoption Accelerates

Shares of Danish pharmaceutical giant Novo Nordisk A/S (NYSE:NVO) experienced sharp volatility following its latest quarterly results. On the August 12 episode of Mad Money, Jim Cramer pointed out the disconnect between the company's strong performance and Wall Street's initial negative knee-jerk reaction. Cramer …

NOVOBN main company NVON main company NOVO-B main company N1VO34 main company NVO main company NNO2 main company +1 more
Sharemaestro market context Trend signal started 52 weeks -24.4% · Next-week setup negative 40.6% NOVOBN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Innoviz Technologies (INVZ) seeks reverse split authority and director votes amid Nasdaq notice

Innoviz Technologies (INVZ) will hold an annual general meeting on September 16, 2026, where shareholders will vote on re-electing several Class II and Class III directors. A key proposal seeks authorization for the board to implement a reverse share split at a ratio between …

INVZ main company
Sharemaestro market context Price below Trend Line 52 weeks -77.5% · Next-week setup negative 40.3% INVZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026

SS Innovations CEO Sudhir Srivastava Gifts 10,000 Shares of Common Stock

Sudhir Srivastava, Chairman and CEO of SS Innovations International, Inc. (NASDAQ:SSII), reported a gift of 10,000 shares of the company's common stock on August 14, 2026. This transaction was executed at no cost, and following the gift, Srivastava indirectly holds over 108 million shares …

SSII main company
Sharemaestro market context Price below Trend Line 52 weeks -44.3% · Next-week setup negative 37.8% SSII stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Enova International (ENVA) boosts $300M facility and prices $300.9M consumer loan ABS

Enova International, through its indirect subsidiary NC LOC 2024, has increased its revolving credit facility to $300 million from $200 million, extended its term, and reduced the borrowing rate. Additionally, another indirect subsidiary, NetCredit Combined Receivables B, LLC, priced $300.9 million in asset-backed notes, …

ENVA main company
Sharemaestro market context Trend signal active 52 weeks +132.9% · Next-week setup positive 58.0% ENVA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Annovis Bio (NYSE:ANVS) Posts Quarterly Earnings Results, Beats Estimates By $0.04 EPS

Annovis Bio reported a Q2 2026 EPS of $(0.40), exceeding the analyst estimate of $(0.45), despite widening its net loss to $14.8 million primarily due to a 131% increase in R&D expenses. The company achieved full enrollment of 850 patients in its pivotal Phase …

ANVS main company
Sharemaestro market context Price below Trend Line 52 weeks -21.9% ANVS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Terra Innovatum Global (NKLR) widens loss, carries $115.5M deficit and large contingent liabilities

Terra Innovatum Global (NKLR), a pre-revenue developer of the SOLO micro-modular nuclear reactor, reported a significantly widened net loss of $25.2 million for the first half of 2026, up from $2.6 million in 2025. The company also disclosed a substantial shareholders' deficit of $115.5 …

NKLR main company
Sharemaestro market context Trend signal started 52 weeks -41.3% · Next-week setup negative 42.2% NKLR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

INNOVATE Corp. (VATE) interim CEO Paul Voigt reports 7.4% ownership

INNOVATE Corp.'s interim CEO, Paul Voigt, has reported beneficial ownership of 1,031,295 shares of common stock, representing 7.4% of the company. This includes shares held directly, through a revocable trust, and an LLC, as well as 300,000 shares issuable upon the exercise of stock …

VATE main company
Sharemaestro market context Price below Trend Line 52 weeks +63.1% VATE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ANVS: Net loss rose sharply as clinical trial costs surged, with cash runway only through Q4 2026

Annovis Bio (ANVS) reported a significant widening of its net loss to $14.8M for Q2 2026 and $32.4M for the first half, primarily due to increased R&D and G&A expenses as late-stage clinical trials advanced. The company's current cash of $18.7M is projected to …

ANVS main company
Sharemaestro market context Price below Trend Line 52 weeks -21.9% ANVS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ANVS: Alzheimer's Phase 3 trial fully enrolled; R&D costs and net loss per share increased year-over-year

Annovis Bio (ANVS) has fully enrolled its pivotal Alzheimer's Phase 3 trial, with topline data anticipated in Q1 2027. The company experienced a sharp increase in research and development expenses, leading to a higher net loss per share year-over-year. Additionally, enrollment continues for the …

ANVS main company
Sharemaestro market context Price below Trend Line 52 weeks -21.9% ANVS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Rubric Capital discloses 3.9M-share Enovis (ENOV) position in Schedule 13G

Rubric Capital Management LP and David Rosen have jointly filed a Schedule 13G, disclosing beneficial ownership of 3,900,000 shares of Enovis Corporation (ENOV) common stock. This position represents 6.78% of the company's outstanding shares, based on 57,562,603 shares as of May 1, 2026. Both …

ENOV main company
Sharemaestro market context Trend signal active 52 weeks -17.1% ENOV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Bank of America Revamps Lenovo Stock Price Target for 2026

This article first appeared on GuruFocus. Bank of America upgraded Lenovo (LNVGF) (LNVGY) to Buy from Neutral after a blowout fiscal first quarter, arguing that a sharp acceleration in servers is changing the earnings profile of a company still widely associated with PCs. The …

0992 main company LENOVO13 main company
Sharemaestro market context Trend signal active 52 weeks +215.9% 0992 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

SS Innovations International (SSII) Reports Record Q2 Revenue of $13.9M, Up 39.4%

SS Innovations International (SSII) announced record second-quarter 2026 revenue of $13.9 million, a 39.4% increase year-over-year, driven by a 30.4% rise in SSi Mantra surgical robotic system installations. The company reported a gross profit of $7.1 million and a cumulative installed base of 224 …

SSII main company
Sharemaestro market context Price below Trend Line 52 weeks -44.3% · Next-week setup negative 37.8% SSII stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context